Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Announces New Brand Positioning and Visual Identity in North America
Press Release: Oregon And 43 States Sue Teva Pharmaceuticals Over Price Fixing for Generic Drugs | The Lund Report
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx | Fierce Pharma
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Pharmaceuticals (@TevaUSA) / Twitter
FDA Signals Shortage For Teva Pharma's ADHD Drug Due To Manufacturing Delay
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews
The Adderall supply squeeze in the US is growing
New York jury holds drug firm Teva liable in opioid crisis - KSTP.com 5 Eyewitness News
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva shares surge after announcing global opioid settlement
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Adderall suffers supply shortages as ADHD diagnoses soar | Fierce Pharma
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript
